128 related articles for article (PubMed ID: 19156380)
1. [Temporal trends in the use of drug-eluting stents in German clinical practice].
Klein B; Zahn R; Heer T; Hochadel M; Tebbe U; Darius H; Kerber S; Schumacher B; Grube E; Hauptmann KE; Glunz HG; Senges J; Zeymer U
Herz; 2008 Sep; 33(6):450-4. PubMed ID: 19156380
[TBL] [Abstract][Full Text] [Related]
2. The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry.
Zahn R; Hamm CW; Schneider S; Zeymer U; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Sabin G; Nienaber CA; Pfannebecker T; Senges J;
Clin Res Cardiol; 2007 Aug; 96(8):548-56. PubMed ID: 17534566
[TBL] [Abstract][Full Text] [Related]
3. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
4. Incications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003. Results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK).
Zeymer U; Zahn R; Hochadel M; Bonzel T; Weber M; Gottwik M; Tebbe U; Senges J
Z Kardiol; 2005 Jun; 94(6):392-8. PubMed ID: 15940439
[TBL] [Abstract][Full Text] [Related]
5. Temporal trends in the use of drug-eluting stents for approved and off-label indications: a longitudinal analysis of a large multicenter percutaneous coronary intervention registry.
Gualano SK; Gurm HS; Share D; Smith D; Aronow HD; LaLonde T; Bates ER; Changezi H; McNamara R; Moscucci M
Clin Cardiol; 2010 Feb; 33(2):111-6. PubMed ID: 20186993
[TBL] [Abstract][Full Text] [Related]
6. "Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry.
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J
Z Kardiol; 2004 Apr; 93(4):287-94. PubMed ID: 15085373
[TBL] [Abstract][Full Text] [Related]
7. [Percutaneous coronary interventions : Use between 2004 and 2012 in Germany].
Ohlmeier C; Czwikla J; Enders D; Mikolajczyk R; Blindt R; Horenkamp-Sonntag D; Linder R; Garbe E
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jun; 59(6):783-8. PubMed ID: 27188620
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
9. [Can PCI with drug-eluting stents replace coronary artery bypass surgery? A comparative economic analysis regarding both therapeutic options based on clinical 12-month data reflecting the German social health care insurance system].
Fricke FU; Silber S
Herz; 2005 Jun; 30(4):332-8. PubMed ID: 15965811
[TBL] [Abstract][Full Text] [Related]
10. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
Huang HW; Brent BN; Shaw RE
Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 18-month angiographic results from the GERSHWIN Study.
Brüggenjürgen B; McBride D; Bode C; Hamm CW; Kuck KH; Willich SN
Herz; 2007 Dec; 32(8):650-5. PubMed ID: 18060612
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
[TBL] [Abstract][Full Text] [Related]
13. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
[TBL] [Abstract][Full Text] [Related]
14. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Sarno G; Lagerqvist B; Fröbert O; Nilsson J; Olivecrona G; Omerovic E; Saleh N; Venetzanos D; James S
Eur Heart J; 2012 Mar; 33(5):606-13. PubMed ID: 22232428
[TBL] [Abstract][Full Text] [Related]
15. Use of drug-eluting stents in Victorian public hospitals.
Yan BP; Ajani AE; Duffy SJ; New G; Horrigan M; Szto G; Walton A; Eccleston D; Lefkovits J; Black A; Sebastian M; Brennan AL; Reid CM; Clark DJ
Med J Aust; 2006 Oct; 185(7):363-7. PubMed ID: 17014403
[TBL] [Abstract][Full Text] [Related]
16. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
[TBL] [Abstract][Full Text] [Related]
17. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
20. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
